During an investigation of the serotonin content of normal and schizophrenic blood sera, it was observed that many sera from severely schizophrenic patients contained a substance which augmented the response (contraction) of the isolated rat uterus to serotonin. Doses of serotonin which were too small to cause a contraction of the uterus by themselves did so when dilutions of these sera were added. Dilutions of the sera as great as 1: 1,000 or even, in some cases, as great as 1: 10,000 produced the synergism to serotonin so that it was plain that the effect was not due to excessive amounts of serotonin in the schizophrenic sera (see Table 1 ). Furthermore, dilutions of the sera themselves caused no contraction, and dialysis of the sera or treatment with acetone effectively removed serotonin without loss of the synergist. These experiments showed again that the effects observed were not to be explained on the basis of excess serotonin in the sera from schizophrenic patients. Sera from normal human beings also contained some of the synergist but the amount present in normal tissue was much less than in sera from many schizophrenic patients. For example, the synergistic activity of most normal sera vanished at a dilution of about 1:100, whereas, as just stated, a good schizophrenic serum could be shown to contain synergist at a dilution of 1:10,000. Normal rat brain also contained the synergist, and from that tissue it could be obtained by extraction with a mixture of chloroform and methanol, and it passed into the aqueous phase when such an extract was mixed with one fifth of its volume of water as in the Folch method" 2for the isolation of gangliosides.
Because it was believed that this synergist might possibly have some relationship to the symptomatology of schizophrenia, an effort was made to purify it and to learn something of its chemical nature. The present paper was designed to report some of the findings. The synergist appeared to be a ganglioside because it was soluble in a mixture of 2:1 chloroform-methanol (hence not a protein), because aqueous solutions of it were stable to boiling or to digestion with proteolytic enzymes such as trypsin and chymotrypsin, and because the substance was destroyed by digestion with neuraminidase. The conclusion that the synergist was probably a ganglioside takes on added interest when one remembers that the hormonal receptor for serotonin in tissues has been shown to be a special specific ganglioside.3 Possibly the synergist adheres to the serotonin receptor in the uterus and provides additional sites for the functioning of serotonin, thereby increasing the sensitivity of the tissue to serotonin. Such a view would be compatible with the observed fact that, although the syiiergist increased the sensitivity to serotonin of rat uterus, it did not increase the sensitivity of a more sensitive tissue, viz. rat stomach fundus strip.
Method of Assay.-Blood was collected and allowed to clot at room temperature for not longer than 2 hr. The serum was then separated by centrifugation and immediately diluted with modified Ringer's solution4 and assayed. Considerable loss of potency occurred when solutions were stored either at 40 or at -16°.
The uterus from an estrogenized rat was suspended from the end of a lightweight chymograph lever so that the tissue was suspended in 10 ml of modified Ringer's solution in a tissue bath maintained at 30°, as in the usual method for the assay of serotonin.4 It was advisable to require the tissue to lift a large load, therefore a writing lever of low inertia was employed such as the no. 222 of the Harvard Instrument Company. A 2-gm weight was placed on the lever 5 cm from the fulcrum after the tissue had been attached 2.5 cm from the fulcrum on the other end of the lever, and balanced with a suitable weight so that the lever was horizontal before addition of the 2-gm weight. The tissue was thus required to lift 5/2.5 X 2 gm in addition to overcoming the inertia of the balanced lever assembly. This increased load reduced the sensitivity of the assay, but increased its precision.
The tissue was then standardized with serotonin. Graded doses were added to the bath, and the sizes of the contractions elicited were measured on a chymograph drum. Care was taken to make sure that the values were reproducible. A "challenging dose" of serotonin (for example, in Table 1 the challenging dose was 0.01 ,ug per 10 ml) was selected as the minimal amount which just failed to elicit a contraction of less than 1 cm. All contractions were measured on a chymograph drum and included the magnification introduced by the use of the lever. The magnification of the contraction of the tissue was eightfold. For most tissues this challenging dose was 0.01 jug of serotonin creatinine sulfate added in a volume of 1 ml to a bath volume of 9 ml so that the final concentration of serotonin creatinine sulfate in the bath was 0.001 1Ag per ml. A time of 120 sec was allowed for the contraction, and the tissue and bath were then drained and thoroughly washed with 10-ml portions of the modified Ringer's solution. However, if maximal contraction occurred before 120 sec, the washing was started once it was clear from the chymograph record that relaxation had commenced. Usually four washings of 10 ml each were sufficient, but washing was continued until relaxation to the original position of the tissue had occurred. Graded doses of the unknown solution of synergist were then added successively to the bath, each followed by the predetermined challenging dose of serotonin, and the contractions elicited were measured. A small amount of the synergist was first applied and if this caused no synergism, a threefold larger amount was next applied and so on, until an amount was found which caused a contraction of at least 3 cm when the challenging dose of serotonin was applied. The tissue was then washed frequently and again tested with the challenging dose of serotonin, and this was continued until the challenging dose produced the original response elicited by the challenging dose alone. The tissue was then ready for a new sample of synergist. After the tissue had received a large amount of synergist, much washing was often required before it regained its original sensitivity to serotonin. The unknown sample of synergist was always added in a volume of 1 ml of the modified Ringer's solution.
A standard solution of the synergist was required for the assay. This was not easy to provide because of the marked instability of the substance. Aqueous solutions lost potency when stored at 00 or when stored frozen (loss of 67% in 24 hr frozen), and dried specimens even of highly purified material also lost potency when stored in the cold. In one instance a dry, purified sample lost 99% of its potency during 4 months at 4°. Consequently, the use of a standard stock was out of the question. The most reliable standard proved to be either blood serum freshly taken from a normal adult male human being, or an extract of normal rat brain made in the following way. A brain from a normal adult rat was removed immediately after death aid was homogenized in 2:1 (by vol) of chloroform-methanol. A volume of solvent 20 times that of the brain w-as used. The suspension was filtered and the precipitate wl-as washed with chloroformr-methaiiol; the extract so obtained was shaken with 1/5 of its volume of distilled water. The mixture was centrifuged and the clear upper phase was removed, diluted with methanol, and concentrated under reduced pressure below 300 to dryness. The residue was then dissolved in enough modified Ringer's solution so that each ml of the solution was equivalent to 100 mg of fresh brain. It was necessary to use this solution in the assay within 2 hr of its preparation. It. (1o1ld 1not be stored even in the cold without loss of potency.
Units.-Three kinds of units were found useful, a 1-cm increase unit (OCIU), a threefold increase unit (TFIU), and a relative rat brain unit (RRBU). Anl amount of material was said to have 1 OCIU if in the assay the addition of it resulted in anl increase of 1 cm in the contraction over the contraction caused by the challenging dose of serotonin alone. It had 1 TFIU if addition of it to the bath resulted in a contraction equal to that caused by an amount of serotonin three times the challenging dose in the original testing of the uterine horn with serotonin in the beginning of the assay. It was thus the amount of material required to increase threefold the activity of the challenging dose of serotonin. This unit almost always had to be calculated from the data by graphical means. A RRBU was contained in the amount of material which gave the same response as an equal weight (referred back to weight of fresh brain) of standard rat brain extract prepared in the way just described. Consequently, the RRBU was the only one of the units which was independent of the sensitivity to synergist of the individual uterus.
In more than 60 experiments oin the assay of blood sera for the synergist, 1 TFIU equalled approximately 1-3 OCIU. Usually, 1 TFIU was present in about 20 mg of fresh rat brain, but in one experiment, 1 TFIU was found in 1 mg and in another experiment, in 48 mg of fresh brain. These variations in the potency of brain could reflect differences in the sensitivity of various uterine tissues to the synergist, or could reflect differences in the amount of synergist present in individual rat brains. However, it would seem more probable that normal brains would contain the same amount of such a substance, and hence that the variation in values for TFIU per mg of brain was reflecting differences in sensitivity to the synergist of individual uteri. A direct experimental test of this point, however, could not be made because of the impossibility of storage of samples of the synergist without loss of potency. If the standard solution could have been assayed oin succeeding days with two different uteri without fear of loss of synergist during storage of the solution, this point could have been settled. The presumed variation in the sensitivity of different uteri made it most advisable to use the relative units when different sera were being compared for relative content of synergist in a series of experiments. Either rat brain extract or fresh human blood serum could have been used as standard in the assay. Conceivably, one could have a relative serum unit as well as a relative rat brain unit, but the uncertainty as to whether normal sera always had a constant amount of the synergist made the rat brain extract seem more desirable as a standard. As will be shown in a succeeding section of this paper, assays of fresh normal human sera also indicated that the sensitivity of various uterine horns probably did differ, because the normal sera ranged from 30 to 200 OCIU per ml. This variation could, of course, also be explained as a real variation in the actual content of synergist in different samples as well as the result of a variation of sensitivity of individual uterine horns.
Purification of the Synergist.-Pooled fresh serum (150 ml, 95,000 OCIU) from severely schizophrenic men5 was poured slowly into 3 liters of cold chloroformmethanol (2:1 by vol) which was being stirred vigorously. The suspension was filtered by gravity, and the precipitate was washed with chloroform-methanol. The combined filtrate and washings (3,150 ml) were shaken with 626 ml of water. The clear top phase was separated, and the bottom phase was washed with fresh "upper phase." 1 No additional activity was removed from the bottom phase by extraction of it with aqueous salt solutions. The top phase was concentrated under reduced pressure (with addition of methanol to control frothing) to about 25 ml, and the concentrated solution was rinsed into a cellophane Visking sausage casing and dialyzed against frequent changes of large volumes of cold (40) water for 2 days.
The nondialyzable solution (30,000 OCIU) was then concentrated under reduced pressure below 30°to dryness, and the residue was triturated with 25 ml of methanol. The soluble portion contained the activity and weighed 8.9 mg. The concentrated synergist was therefore detectable at less than 1 -y per ml. The material was a white, amorphous solid, readily soluble in water or in methanol.
When the concentrate was stored at 40 in the dark, either as a dry solid or in solution, it slowly developed a brown and then a black color and a tarry precipitate, just as phenols or aromatic amines are known to do when they oxidize. As mentioned previously, a steady loss of potency also occurred during storage.
When a methanolic solution (10 mg per ml) of the concentrate was spotted or streaked on a plate of silicic acid H (previously activated by heating at 140°o vernight) and the plate was developed in the usual way for thin-layer chromatography3' 6 in an atmosphere of nitrogen with a solvent composed of chloroformmethanol-water 60:35:8 through which nitrogen had been bubbled before use, and various sections of the developed chromatogram were eluted with the modified Ringer's solution or with chloroform, methanol, water 9:9:1.8, the synergistic activity for serotonin was found to migrate with an Rf of 0.15. When nitrogen was not used in such an experiment, no activity was recovered from any portion of the chromatogram, presumably because of oxidative destruction during contact with air. When a developed chromatogram was exposed to iodine vapors, a brown spot of Rf 0.15 was observed. The active material tended to streak badly in the chloroform-methanol-water solvent, but when the water was replaced by an equal amount of 4 11 aqueous ammonium hydroxide,6 a sharp definition of the active zone was obtained without change in Rf.
Destruction by Neuraminidase.-When either crude or purified synergist was digested at pH 6.0 and 30°with neuraminidase, there was loss of activity, provided that the neuraminidase was the enzyme from Clostridium perfringens and that EDTA (ethylenediamine tetraacetate) was simultaneously present.7' 8 The neuraminidase from Vibrio cholerae did not cause any loss of activity. In a typical experiment, 20 OCIU of the purified synergist in 1 ml of 0.15 M sodium acetate buffer, and 0.5 mg per ml of EDTA at pH 6.0, plus 0.0015 micromolar units of CU. perfringens neuraminidase were incubated 2 hr at 300. Controls lacking enzyme to check on possible loss of potency of the synergist during incubation were always included. Assay for synergist showed that less than 2 OCIU remained in the solution which contained the EDTA and Cl. perfringens neuraminidase, whereas, when the EDTA or the neuraminidase or both were omitted, 20 OCIU of synergist were found. When the EDTA was omitted, and neuraminidase from Vibrio cholerae (50 units) replaced the Cl. perfringen-s enzyme, 20 OCIU were found after the incubation.
Lack of Synergist Potency in Known Gangliosides.-Various known gangliosides were assayed for potency as serotonin synergist. No appreciable activity was found. For example, a sample of mixed gangliosides isolated from calf brain and provided by Dr. C. W. de Fiebre of Wilson Laboratories., Chicago, exhibited practically no activity. This was not unexpected in view of the fact that these gangliosides had been stored for long periods as a dried powder. Samples of highly purified monosialo gangliosides, IG and FM (Tay-Sachs' ganglioside), and of the disialo gangliosides, 2G and 3G, all of which had been kindly supplied by Dr. R. H. MeCluer of Ohio State University Hospitals, showed no significant activity up to 0.1 mg per ml. It was therefore clear that the known gangliosides were not active as the serotonin synergist.
Synergist in Normnal Blood Sera.-Fresh sera from 12 normal adult male human beings when assayed in the way described contained 30-200 OCIU per ml. In the assay of normal female sera there was a suggestion that sera taken in the premenstrual phase might have larger amounts of the synergist, but the numbers of samples available were not sufficient to establish this point.
Synergist in Sera from Schizophrenic Human Beings.-Fresh sera taken from 28 human beings diagnosed by competent psychiatrists as having typical schizophrenia were obtained through the cooperation of Professor W. T. Lhamon and Dr. L. Bigelow of the New York Hospital, and from other physicians.5 These were assayed for serotonin synergist in the way described. Of the 28 sera studied, ten contained more than 1000 OCIU. To determine whether assay for serotonin synergist might constitute a valid test for schizophrenia, three series of blind experiments were performed. In these, sera were taken from normal hospital staff, from patients hospitalized (for nonschizophrenic psychiatric disease), and from schizophrenic hospitalized persons. The sera were submitted with coded numbers, such that the assayist did not know the clinical diagnosis for each number. An effort was made to determine whether the assay for excess synergist would be able to distinguish schizophrenic from nonschizophrenic individuals.
In the first series there were 12 sera, eight from normal or nonschizophrenic and four from schizophrenic individuals according to clinical diagnosis. Elevated synergist was found in three of the schizophrenic and one of the nonschizophrenic cases. It was of some interest that in one of the nonschizophrenic persons in whom elevated synergist level was found, there had been some clinical disagreement about the diagnosis, in that some opinions had it that the patient was schizophrenic, whereas others disagreed.
In the second series the correspondence between diagnosis of schizophrenia and the finding of increased synergist was poor. There were nine schizophrenics of whom only four were placed correctly, and there were 11 nonschizophrenics of whom only eight were placed correctly. Three of the nonschizophrenics had elevated levels of synergist in their sera, and five of the schizophrenic patients failed to show increased synergist in their sera. This second series of individuals consisted mainly of females so that the interpretation could have been obscured if, as mentioned earlier., premenstrual tension is accompanied by increased synergist in the blood.
The third series consisted entirely of males but here the correspondence between The partially purified serotonin synergist was that portion of an active seruin, fromi a severe schizophrenic patient, which remained soluble in chloroform: methanol when the fractionation operations were as described earlier in this paper.
diagnosis of schizophrenia and elevated serotonin synergist in the sera also w-as not striking. There were ten in this series of whom five were schizophrenic and five were nonschizophrenic psychiatric patients. Three of the schizophrenic individuals showed high levels of synergist, but the other two and the nonschizophrenic patients had essentially normal levels. Although the test for elevated serotonin synergist did not seem to offer great promise as a diagnostic test for schizophrenia, there was one clue obtained with it which may eventually help in understanding the cause of the symptomatology in the disease. This was that all of the schizophrenic persons who showed high levels of synergist in their sera presented a recent history of agitation and even of physical assaults on other persons. This would fit well with what is known from other studies to be the signs of excess serotonin in the brain.9 It may also be that an additional chance observation, made during the examination of the three series, may have clinical interest. This was that several of the nonschizophrenic persons who were found to have high levels of serotonin synergist in their sera had a clinical diagnosis of chronic alcoholism. Thus, in the three series mentioned earlier, four individuals with a history of alcoholism showed a high level of serotonin synergist. No attempt was made to discover whether all psychiatric patients with a diagnosis of alcoholism would exhibit increased serotonin synergist.
Acetylcholitne Synergist in Schizophrenic Sera.-The sera from schizophrenic patients which enhanced the activity of serotonin also enhanced the activity of acetylcholine and of bradykinin. The test for these synergists were performed in the same way as for the serotonin synergist except that acetylcholine or bradykinin instead of serotonin was used with the rat uterus. It was not determined whether the synergist for acetylcholine was identical to the one for serotonlin. All that was found about this was that the acetylcholine synergist was present in the ganglioside fraction of the sera. Whether or not these two synergists can be separated by thinlayer chromatography was not determined.
Summary.-A substance which increased the sensitivity to serotonin of isolated rat uteri was detected in the blood sera of some schizophrenic human beings. A similar substance was present in normal sera, but in smaller amounts. It was also present in normal rat brain. A method for assay of this synergist was described.
